We are live on
!
Find out more
MIM
MetLife Investment Management Portfolio holdings
AUM
$19.6B
1-Year Est. Return
32.64%
This Fund
S&P 500
This Quarter
Est. Return
+9.69%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$13.7B
AUM Growth
-$178M
(-1.3%)
Cap. Flow
-$1.14B
Cap. Flow
% of AUM
-8.27%
Top 10 Holdings %
Top 10 Hldgs %
25.57%
Holding
3,040
New
254
Increased
776
Reduced
1,044
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$14.9M |
| 2 |
Palo Alto Networks
PANW
|
+$14.8M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$9.08M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$7.73M |
| 5 |
Crown Holdings
CCK
|
+$5.37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$901M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$71.6M |
| 3 |
Apple
AAPL
|
+$11.2M |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$10.7M |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$8.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.03% |
| 2 | Healthcare | 12.56% |
| 3 | Financials | 11.14% |
| 4 | Consumer Discretionary | 11.02% |
| 5 | Industrials | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Entrada Therapeutics
TRDA
$290M
| $177K | ﹤0.01% |
+11,694
| New | +$161K |
|
2352
Viemed Healthcare
VMD
$349M
| $177K | ﹤0.01% |
+18,101
| New | +$184K |
|
2353
Atea Pharmaceuticals
AVIR
$406M
| $177K | ﹤0.01% |
47,234
| – | – |
|
2354
Mid Penn Bancorp
MPB
$971M
| $176K | ﹤0.01% |
7,993
| – | – |
|
2355
Phathom Pharmaceuticals
PHAT
$743M
| $176K | ﹤0.01% |
12,302
| – | – |
|
2356
Citizens Financial Services
CZFS
$393M
| $176K | ﹤0.01% |
+2,410
| New | +$196K |
|
2357
Brown-Forman Class A
BF.A
$13.1B
| $176K | ﹤0.01% |
2,585
+577
| +29% | +$37.6K |
|
|
BAND
2358
Bandwidth Inc
BAND
$1.74B
| $176K | ﹤0.01% |
12,851
| – | – |
|
2359
Omeros
OMER
$1.26B
| $176K | ﹤0.01% |
+32,266
| New | +$188K |
|
2360
NerdWallet
NRDS
$639M
| $176K | ﹤0.01% |
18,653
+3,505
| +23% | +$39.6K |
|
2361
Cabaletta Bio
CABA
$442M
| $175K | ﹤0.01% |
+13,569
| New | +$147K |
|
2362
Alerus Financial
ALRS
$844M
| $175K | ﹤0.01% |
9,726
+2,401
| +33% | +$38.9K |
|
2363
Bowman Consulting
BWMN
$731M
| $175K | ﹤0.01% |
+5,483
| New | +$160K |
|
2364
Peoples Financial Services
PFIS
$717M
| $174K | ﹤0.01% |
3,977
| – | – |
|
2365
LSI Industries
LYTS
$912M
| $174K | ﹤0.01% |
+13,861
| New | +$174K |
|
|
TDAY
2366
USA Today Co
TDAY
$1B
| $174K | ﹤0.01% |
77,170
| – | – |
|
2367
Butterfly Network
BFLY
$2.36B
| $173K | ﹤0.01% |
75,263
+20,679
| +38% | +$46.2K |
|
2368
The RMR Group
RMR
$346M
| $173K | ﹤0.01% |
7,468
| – | – |
|
|
ALPN
2369
DELISTED
Alpine Immune Sciences Inc
ALPN
| $173K | ﹤0.01% |
16,818
+4,790
| +40% | +$43.2K |
|
2370
Americold
COLD
$4.32B
| $173K | ﹤0.01% |
5,348
-219
| -4% | -$6.52K |
|
2371
Global Industrial
GIC
$1.49B
| $173K | ﹤0.01% |
6,216
| – | – |
|
2372
Riley Exploration Permian
REPX
$786M
| $173K | ﹤0.01% |
4,831
-2,327
| -33% | -$90.8K |
|
2373
Northeast Bank
NBN
$1.16B
| $172K | ﹤0.01% |
4,124
+536
| +15% | +$20.3K |
|
2374
RingCentral
RNG
$5.66B
| $172K | ﹤0.01% |
5,240
+78
| +2% | +$2.4K |
|
|
AYX
2375
DELISTED
Alteryx Inc
AYX
| $171K | ﹤0.01% |
3,761
+123
| +3% | +$5.39K |
|
Similar funds
PCM
HHII
EIM
P
BPA
NAM
MIC
MetLife Investment Management's Q2 2023 Portfolio in Review
As of Q2 2023, MetLife Investment Management held 3,040 positions worth $13.7B, down 1.3% from $13.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
MetLife Investment Management withdrew a net $1.14B in Q2 2023, closing 100 positions and reducing 1,044 holdings. Its most notable exit was Evoqua Water Technologies Corp. Common Stock, an estimated $3.05M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
Against the trend, MetLife Investment Management opened a new position in Knife River worth $2.46M.
- MetLife Investment Management's largest Q2 2023 buy was Knife River: 56,478 shares worth $2.46M.
- MetLife Investment Management added most to Meta Platforms (Facebook) in Q2 2023, an estimated $14.9M increase.
- MetLife Investment Management's biggest Q2 2023 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $901M.
- MetLife Investment Management fully exited Evoqua Water Technologies Corp. Common Stock in Q2 2023, selling an estimated $3.05M.
- MetLife Investment Management's ten largest holdings make up 26% of its $13.7B portfolio in Q2 2023.
- MetLife Investment Management opened 254 new positions and closed 100 in Q2 2023.
- MetLife Investment Management's portfolio value fell 1.3% quarter-over-quarter to $13.7B.
Based on MetLife Investment Management's 13F filing for Q2 2023, filed 10 Aug 2023.